Article Versions Notes

Nakajima R, Zhao L, Zhou Y, Shirasawa M, Uchida A, Murakawa H, Fikriyanti M, Iwanaga R, Bradford AP, Araki K, et al. Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool. Genes. 2023; 14(2):393. https://doi.org/10.3390/genes14020393

Nakajima, Rinka, Lin Zhao, Yaxuan Zhou, Mashiro Shirasawa, Ayato Uchida, Hikaru Murakawa, Mariana Fikriyanti, Ritsuko Iwanaga, Andrew P. Bradford, Keigo Araki, and et al. 2023. "Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool" Genes 14, no. 2: 393. https://doi.org/10.3390/genes14020393

Nakajima, R., Zhao, L., Zhou, Y., Shirasawa, M., Uchida, A., Murakawa, H., Fikriyanti, M., Iwanaga, R., Bradford, A. P., Araki, K., Warita, T., & Ohtani, K. (2023). Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool. Genes, 14(2), 393. https://doi.org/10.3390/genes14020393